These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 28782196)

  • 1. Multiregional dysmotility in diabetes mellitus assessed using the wireless motility capsule.
    Brock C; Drewes AM; Farmer AD
    Neurogastroenterol Motil; 2017 Sep; 29(9):. PubMed ID: 28782196
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to multiregional dysmotility in diabetes mellitus assessed using the wireless motility capsule.
    Rouphael C; Thota PN; Cline M
    Neurogastroenterol Motil; 2017 Sep; 29(9):. PubMed ID: 28782195
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of wireless motility capsule in the assessment and management of gastrointestinal dysmotility in patients with diabetes mellitus.
    Rouphael C; Arora Z; Thota PN; Lopez R; Santisi J; Funk C; Cline M
    Neurogastroenterol Motil; 2017 Sep; 29(9):. PubMed ID: 28444862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of wireless motility capsule in patients with suspected multiregional gastrointestinal dysmotility.
    Arora Z; Parungao JM; Lopez R; Heinlein C; Santisi J; Birgisson S
    Dig Dis Sci; 2015 May; 60(5):1350-7. PubMed ID: 25399332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Wireless Motility Capsule: a One-Stop Shop for the Evaluation of GI Motility Disorders.
    Saad RJ
    Curr Gastroenterol Rep; 2016 Mar; 18(3):14. PubMed ID: 26908282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of gastrointestinal transit in clinical practice: position paper of the American and European Neurogastroenterology and Motility Societies.
    Rao SS; Camilleri M; Hasler WL; Maurer AH; Parkman HP; Saad R; Scott MS; Simren M; Soffer E; Szarka L
    Neurogastroenterol Motil; 2011 Jan; 23(1):8-23. PubMed ID: 21138500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic utility of wireless motility capsule in gastrointestinal dysmotility.
    Rao SS; Mysore K; Attaluri A; Valestin J
    J Clin Gastroenterol; 2011 Sep; 45(8):684-90. PubMed ID: 21135705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Video-capsule endoscopy gastric and small bowel transit time and completeness of the examination in patients with diabetes mellitus.
    Triantafyllou K; Kalantzis C; Papadopoulos AA; Apostolopoulos P; Rokkas T; Kalantzis N; Ladas SD
    Dig Liver Dis; 2007 Jun; 39(6):575-80. PubMed ID: 17433797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal function in diabetes is affected regardless of asymptomatic appearance.
    Wegeberg AM; Bertoli D; Ejskjaer N; Brock B; Drewes AM; Brock C
    J Intern Med; 2022 Apr; 291(4):505-512. PubMed ID: 34839554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Motility-recording capsule simplifies gastrointestinal examination. Safe diagnostics in motility disorders].
    Diaz H; Sjöström U; Lindberg G; Hellström PM
    Lakartidningen; 2016 Apr; 113():. PubMed ID: 27070390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of the wireless motility capsule and lactulose breath testing in the evaluation of patients with Parkinson's disease who present with functional gastrointestinal symptoms.
    Su A; Gandhy R; Barlow C; Triadafilopoulos G
    BMJ Open Gastroenterol; 2017; 4(1):e000132. PubMed ID: 28321329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional gastrointestinal contractility parameters using the wireless motility capsule: inter-observer reproducibility and influence of age, gender and study country.
    Farmer AD; Wegeberg AL; Brock B; Hobson AR; Mohammed SD; Scott SM; Bruckner-Holt CE; Semler JR; Hasler WL; Hellström PM; Drewes AM; Brock C
    Aliment Pharmacol Ther; 2018 Feb; 47(3):391-400. PubMed ID: 29210098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 1 diabetic patients with peripheral neuropathy have pan-enteric prolongation of gastrointestinal transit times and an altered caecal pH profile.
    Farmer AD; Pedersen AG; Brock B; Jakobsen PE; Karmisholt J; Mohammed SD; Scott SM; Drewes AM; Brock C
    Diabetologia; 2017 Apr; 60(4):709-718. PubMed ID: 28105520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional gastrointestinal transit and pH studied in 215 healthy volunteers using the wireless motility capsule: influence of age, gender, study country and testing protocol.
    Wang YT; Mohammed SD; Farmer AD; Wang D; Zarate N; Hobson AR; Hellström PM; Semler JR; Kuo B; Rao SS; Hasler WL; Camilleri M; Scott SM
    Aliment Pharmacol Ther; 2015 Sep; 42(6):761-72. PubMed ID: 26223837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decompensated cirrhotics have slower intestinal transit times as compared with compensated cirrhotics and healthy controls.
    Chander Roland B; Garcia-Tsao G; Ciarleglio MM; Deng Y; Sheth A
    J Clin Gastroenterol; 2013; 47(10):888-93. PubMed ID: 23632359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut Transit in Duchenne Muscular Dystrophy Is Not Impaired: A Study Utilizing Wireless Motility Capsules.
    Kraus D; Wong B; Hu S; Kaul A
    J Pediatr; 2018 Mar; 194():238-240. PubMed ID: 29224937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small Intestinal Transit Time Is Delayed in Small Intestinal Bacterial Overgrowth.
    Roland BC; Ciarleglio MM; Clarke JO; Semler JR; Tomakin E; Mullin GE; Pasricha PJ
    J Clin Gastroenterol; 2015 Aug; 49(7):571-6. PubMed ID: 25319735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Clozapine on the Gut: Cross-Sectional Study of Delayed Gastric Emptying and Small and Large Intestinal Dysmotility.
    Every-Palmer S; Inns SJ; Grant E; Ellis PM
    CNS Drugs; 2019 Jan; 33(1):81-91. PubMed ID: 30456745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transit times in capsule endoscopy: are all patients the same?
    Enns R
    Dig Liver Dis; 2007 Jun; 39(6):581-3. PubMed ID: 17459793
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of GLP-1 receptor agonist on gastrointestinal tract motility and residue rates as evaluated by capsule endoscopy.
    Nakatani Y; Maeda M; Matsumura M; Shimizu R; Banba N; Aso Y; Yasu T; Harasawa H
    Diabetes Metab; 2017 Oct; 43(5):430-437. PubMed ID: 28648835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.